Financial reports
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
23 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
9 Nov 23
8-K
Other Events
1 Nov 23
8-K
Termination of a Material Definitive Agreement
3 Aug 23
8-K
Form of Parent Stockholder Voting Agreement
1 Aug 23
8-K
Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results
8 May 23
8-K
Departure of Directors or Certain Officers
13 Mar 23
8-K
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
23 Feb 23
8-K
Results of Operations and Financial Condition
11 Jan 23
8-K
Departure of Directors or Certain Officers
25 Nov 22
8-K
EQRx Provides Portfolio and U.S. Commercial Strategy Updates; Reports Third Quarter 2022 Financial Results
10 Nov 22
Registration and prospectus
15-12G
Securities registration termination
20 Nov 23
POS AM
Prospectus update (post-effective amendment)
9 Nov 23
POS AM
Prospectus update (post-effective amendment)
9 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Nov 23
POS AM
Prospectus update (post-effective amendment)
9 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Nov 23
25-NSE
Exchange delisting
9 Nov 23
425
Business combination disclosure
1 Nov 23
425
Business combination disclosure
23 Oct 23
425
Business combination disclosure
16 Aug 23
Other
EFFECT
Notice of effectiveness
20 Nov 23
EFFECT
Notice of effectiveness
20 Nov 23
EFFECT
Notice of effectiveness
20 Nov 23
EFFECT
Notice of effectiveness
6 Mar 23
EFFECT
Notice of effectiveness
6 Mar 23
CORRESP
Correspondence with SEC
2 Mar 23
CORRESP
Correspondence with SEC
2 Mar 23
UPLOAD
Letter from SEC
1 Mar 23
UPLOAD
Letter from SEC
1 Mar 23
EFFECT
Notice of effectiveness
29 Mar 22
Ownership
SC 13G/A
ARCH Venture Fund X, L.P.
17 Nov 23
SC 13D/A
AH Bio Fund II, L.P.
17 Nov 23
SC 13D/A
Andreessen Horowitz Fund I, L.P.
15 Nov 23
SC 13D/A
Casdin Capital, LLC
15 Nov 23
4
Eli Casdin
14 Nov 23
4
Melanie Nallicheri
9 Nov 23
4
PAUL L BERNS
9 Nov 23
4
SAMUEL J. MERKSAMER
9 Nov 23
4
Sandra Horning
9 Nov 23
4
Dina Ciarimboli
9 Nov 23